- Home
- Media Center
- Press releases
- Medical technologies
Medical technologies
DePuy Synthes Announces Agreement with Materialise for 3D-Printed Titanium Cranio-Facial Implants
In a development that further underscores ways in which medical devices are being personalized for individual patients, DePuy Synthes, part of the Johnson & Johnson family of companies, announced an agreement with Materialise, a leader in 3D printing, to offer TRUMATCH® titanium 3D-printed implants for use in facial and skull disorders.
Johnson & Johnson Vision Care Enters Monthly Category with ACUVUE® VITA™ Brand Contact Lenses
Data Shows New Lens Superior to Leading Competitors in Comfort across 30-Day Wearing Cycle
New Data Show On-Demand, Mealtime Insulin Delivery System Enabled More than 50 Percent of Patients to Report Improved Dose Compliance
Innovative, In-Development Patch Allows Simple and Discreet Dosing and Greater Patient Satisfaction
DePuy Synthes Companies Announces Acquisition Of Biomedical Enterprises, Inc., A Leader In Small Bone Fixation
Acquisition of Nitinol Implant Company Strengthens Johnson & Johnson Medical Devices Position in Elective Extremity Surgery, the Fastest Growing Segment in Orthopaedics
Ethicon Announces Agreement To Acquire NeuWave Medical, Inc.
NeuWave Medical Technology Offers Minimally Invasive Intervention Option for Patients with Soft Tissue Lesions
DePuy Synthes Companies Announces New Strategic Alliance with Experts in Bundled Payments
Part of DePuy Synthes Companies’ Broader Effort to ‘Go Beyond the Implant’
New Onetouch Verio Flex™ Blood Glucose Monitoring System with ColorSure™ Technology Takes the Guesswork Out of Blood Sugar Test Results
-- 9 out of 10 People With Diabetes Agree The System’s Simple Color Range Indicator Helps Them Easily Interpret Their Blood Sugar Readings --
FDA Approves Animas® Vibe® Insulin Pump and Continuous Glucose Monitoring System For Use in Children
Insulin Pump System Offers Children Ages Two and Older an Integrated Solution for Diabetes Management
Biosense Webster, Inc. Announces Acquisition of Coherex Medical, Inc.
The addition of the Coherex WaveCrest® Left Atrial Appendage Occlusion System to the company’s portfolio expands range of treatment options for patients with atrial fibrillatio